ToxNav ® validation data published

Today, Oxford Cancer Biomarkers are pleased to announce the publication of the ToxNav ® clinical validation study in the journal

Read More

Colorectal cancer in the Covid-19 era

Professors David and Rachel Kerr’s proposed colorectal cancer treatment guidelines for patients during the COVID-19 era. AIMS To reduce the

Read More

OCB Backing UK’s Artificial Intelligence Revolution

Press Release Oxford Cancer Biomarkers, Tuesday 6th November 2018. OCB is pleased to announce that it is an SME partner

Read More